https://www.biotechreality.com/2026/10/eli-lilly-sofe-m-platinum-sensitive-ovarian-cancer-esmo-2026.html 2026-10-24T06:52:20Z BiotechReality - Information Intelligence System for Biopharma en Eli Lilly Sofe-M Plus Bevacizumab Delivers 79% Response Rate in Platinum-Sensitive Ovarian Cancer at ESMO 2026 2026-10-24T06:52:17Z Blog https://www.biotechreality.com/2026/10/abbott-q3-2026-results.html 2026-10-24T05:28:45Z BiotechReality - Information Intelligence System for Biopharma en Abbott Q3 2026 Results: Abbott (NYSE: ABT) Posts 14.5% Sales Growth, Reaffirms Full-Year EPS Guidance Midpoint 2026-10-24T05:28:41Z Blog https://www.biotechreality.com/2026/10/charles-river-fda-collaboration.html 2026-10-23T16:44:53Z BiotechReality - Information Intelligence System for Biopharma en Charles River FDA Collaboration With Labcorp Targets New Preclinical Methods for Abuse Potential Assessment 2026-10-23T16:44:48Z Blog